Comments
BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2019 ,inter alia, to consider and approve the following: a) the audited Standalone and Consolidated Financial Statements and Results of the Company for the quarter and financial year ended March 31, 2019; and b) recommend a dividend, if any, for the financial year ended March 31, 2019. Further, pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from April 04, 2019 and will open after the expiry of 48 hours from declaration of the said financial results i.e. May 20, 2019. Kindly acknowledge and take on record the same.
Source : BSE - www.bseindia.com
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.